Rabies

Scientific Basis of the Disease and Its Management

Inbunden, Engelska, 2020

1 728 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.

Beskrivning

Rabies: Basis of the Disease and Its Management, Fourth Edition is an authoritative reference on the current status of rabies, including the virological, clinical, and public health aspects and management recommendations. Rabies remains one of the most important global public health problems worldwide. Although many important developments have been made over the past century to combat this disease, rabies has become a re-emergent infection in the resource-constrained countries. The Fourth Edition updates this classic reference with comprehensive coverage of the molecular virology, pathogenesis, immunology, vaccines, public health aspects, and epidemiology of rabies and is completely revised, with new chapters that will cover historical developments in rabies intervention strategies, the evolution of rabies virus, modeling rabies control, and on the strategy for rabies elimination. Rabies, Fourth Edition, provides physicians, veterinarians, public health advisors, epidemiologists, and research scientists with a single source for authoritative and up-to-date information on the diagnosis, treatment, control, and prevention of this fatal infectious virus.

Edited by renowned researchers in this subject and has gathered a team of experts to detail the science, treatment, and control of rabies
Completely revised, the Fourth Edition presents rabies as a re-emergent infection with emphasis on a global perspective of the disease
Includes new chapters the evolution of the rabies virus and on modeling rabies control and includes many full-color figures that highlight important information

Produktinformation

Utgivningsdatum:2020-05-05
Mått:191 x 235 x 39 mm
Vikt:1 630 g
Format:Inbunden
Språk:Engelska
Antal sidor:732
Upplaga:4
Förlag:Elsevier Science
ISBN:9780128187050

Utforska kategorier

Mer om författaren

Dr. Anthony Fooks is a Virologist and the Lead Scientist for International Development at The Animal and Plant Health Agency in the UK. He is an Honorary Visiting Professor in the Faculty of Health and Life Sciences, University of Liverpool, UK and at the Institute for Infection and Immunity at St George’s Medical School, University of London, UK. His research focuses on rabies pathogenesis and immunity. Dr. Alan C. Jackson is Adjunct Clinical Professor in the Department of Clinical Neurosciences (Neurology) at the University of Calgary in Calgary, Alberta, Canada. Previously, he was Professor of Medicine (Neurology) at Queen’s University (Kingston, Ontario, Canada) and later at the University of Manitoba (Winnipeg, Manitoba, Canada). He graduated from Queen’s University with BA and MD degrees. He completed an internship in internal medicine at University of Southern California, residencies in internal medicine at Queen’s University and in neurology at the University of Western Ontario, and a fellowship in neurovirology at The Johns Hopkins University with Drs. Richard Johnson and Diane Griffin. Dr. Jackson has been active in rabies research for over 30 years.

Recensioner i media

"This is a tremendously comprehensive and well-presented text that will be useful to public health workers, infectious disease specialists, neurologists, and anyone who finds themselves considering a potential rabies case." --Doody

Innehållsförteckning

1. A history of rabies - The foundation for global canine rabies elimination2. Rabies virus3. Evolution of rabies virus4. Epidemiology5. Molecular epidemiology6. Rabies in terrestrial animals7. Bat rabies8. Human disease9. Pathogenesis10. Pathology11. Immunology12. Laboratory diagnosis of rabies13. Measures of rabies immunity14. Human and animal vaccines15. Next generation of rabies vaccines16. Public health management of humans at risk17. Therapy of human rabies18. Dog rabies and its control19. Rabies control in wild carnivores20. Modeling canine rabies virus transmission dynamics21. Strategies for the elimination of dog-mediated human rabies by 203022. Future developments and challenges